Belgium
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 78.57 M
|
Dec. 31, 2023 | USD 23.14 | 1.75% |
|
Belgium |
|
2 |
USD 35.33 M
|
Dec. 31, 2023 | USD 10.80 | 2.86% |
|
Belgium |
|
3 |
USD -796.21 K
|
Dec. 31, 2023 | USD 2.20 | -1.56% |
|
Belgium |
|
4 |
USD -3.93 M
|
Dec. 31, 2023 | USD 1.91 | 0.00% |
|
Belgium |
|
5 |
USD -49.40 M
|
Dec. 31, 2023 | USD 20.10 | 1.93% |
|
Belgium |
|
6 |
USD -485.65 M
|
Dec. 31, 2023 | USD 193.31 | -0.57% |
|
Belgium |
The Healthcare company in Belgium with the highest Net Cash Used For Investing Activities is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at USD 78.57 M.
The Healthcare company in Belgium with the lowest Net Cash Used For Investing Activities is UCB SA (Brussels Stock Exchange: UCB.BR) at USD -485.65 M.
The top 10 Healthcare companies in Belgium by Net Cash Used For Investing Activities are Galapagos NV, Nyxoah S.A., Sequana Medical NV, MDxHealth SA, Fagron NV and UCB SA.
The bottom 10 Healthcare companies in Belgium by Net Cash Used For Investing Activities are UCB SA, Fagron NV, MDxHealth SA, Sequana Medical NV, Nyxoah S.A. and Galapagos NV.